Olaparib in PALB2 Advanced Pancreatic Cancer

Clinical trial NCT06078787 · UNKNOWN

Trial details

NCT number: NCT06078787
Sponsor: Azienda Ospedaliero-Universitaria di Modena
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2023-08-01
Primary completion: 2025-08-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.